206 related articles for article (PubMed ID: 32886320)
21. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
22. [Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate].
Mücke M; Conrad R; Marinova M; Cuhls H; Elsner F; Rolke R; Radbruch L
Schmerz; 2016 Dec; 30(6):560-567. PubMed ID: 27072143
[TBL] [Abstract][Full Text] [Related]
23. A dose titration study of fentanyl buccal soluble film for breakthrough cancer pain in Taiwan.
Chiou TJ; Chao TC; Chao TY; Huang JS; Chang YF; Wang CH
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1179. PubMed ID: 32721110
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain.
Kawana M; Miyasato A; Funato M; Nagatani K; Suzuki N; Onoda C; Fujimoto H; Ohno R; Kusakabe A; Kiribayashi M; Nakamura K; Kondo M; Ozeki A; Okamoto K; Kokubun H
Biol Pharm Bull; 2023; 46(10):1444-1450. PubMed ID: 37779046
[TBL] [Abstract][Full Text] [Related]
25. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
[TBL] [Abstract][Full Text] [Related]
26. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
27. Transdermal fentanyl in postoperative pain.
Lehmann LJ; DeSio JM; Radvany T; Bikhazi GB
Reg Anesth; 1997; 22(1):24-8. PubMed ID: 9010943
[TBL] [Abstract][Full Text] [Related]
28. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
[TBL] [Abstract][Full Text] [Related]
29. Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.
Solassol I; Bressolle F; Caumette L; Garcia F; Poujol S; Culine S; Pinguet F
Ther Drug Monit; 2005 Aug; 27(4):491-8. PubMed ID: 16044107
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
Karlsson M; Berggren AC
Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
[TBL] [Abstract][Full Text] [Related]
31. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
32. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
33. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
34. Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.
Alberts DS; Smith CC; Parikh N; Rauck RL
Pain Manag; 2016 Oct; 6(5):427-34. PubMed ID: 27020837
[TBL] [Abstract][Full Text] [Related]
35. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.
Rauck RL; Tark M; Reyes E; Hayes TG; Bartkowiak AJ; Hassman D; Nalamachu S; Derrick R; Howell J
Curr Med Res Opin; 2009 Dec; 25(12):2877-85. PubMed ID: 19814586
[TBL] [Abstract][Full Text] [Related]
37. Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial.
Ricchini F; Caraceni A; Zecca E; Pigni A; Centurioni F; Manzoni A; Kaasa S; Brunelli C
J Pain Symptom Manage; 2019 Oct; 58(4):587-595. PubMed ID: 31233843
[TBL] [Abstract][Full Text] [Related]
38. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
39. Association of transdermal fentanyl and oral transmucosal fentanyl citrate in the treatment of opioid naive patients with severe chronic noncancer pain.
Collado F; Torres LM
J Opioid Manag; 2008; 4(2):111-5. PubMed ID: 18557168
[TBL] [Abstract][Full Text] [Related]
40. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
